Learn More
Medchemexpress LLC Nilotinib | 641571-10-0 | MFCD09833716 | ≥98.0% | 529.5 g/mol | C28H22F3N7O | 500 MG

Supplier: Medchemexpress LLC HY10159500MG
Nilotinib is an orally available Bcr-Abl tyrosine kinase inhibitor with antineoplastic activity used in research to study BCR-ABL-driven malignancies. It is a potent, selective small-molecule inhibitor intended for research and analytical applications.
- Potent inhibition of Bcr-Abl tyrosine kinase.
- Activity against several imatinib-resistant Bcr-Abl mutants.
- Orally bioavailable small molecule suitable for in vitro and in vivo studies.
- High chemical purity suitable for analytical and research use.
- Defined chemical identity: C28H22F3N7O, MW 529.5 g/mol.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.